Eton Pharmaceuticals Inc. (ETON)
NASDAQ: ETON
· Real-Time Price · USD
17.01
0.31 (1.86%)
At close: Aug 15, 2025, 3:59 PM
17.04
0.18%
After-hours: Aug 15, 2025, 04:10 PM EDT
Eton Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 25.38M | 17.42M | 14.94M | 20.26M | 17.69M | 16.66M | 21.39M | 22.07M | 21.57M | 14.71M | 16.3M | 13.38M | 17.05M | 15.23M | 14.41M | 22.71M | 25.8M | 25.11M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 12K | 12K | 12K | 12K | 12K | 12K | 12K | 12K | 12K | 12K | 12K | 12K | 12K | 12K | 21K | 23K | 32K | 36K |
Receivables | 14.45M | 16.4M | 5.36M | 5.59M | 4.87M | 4.24M | 3.41M | 3.5M | 3.08M | 2.87M | 1.85M | 1.5M | 834K | 796K | 5.47M | 385K | 303K | 300K |
Inventory | 23.79M | 13.62M | 15.23M | 1.94M | 2.07M | 2.32M | 911K | 1.05M | 816K | 437K | 557K | 481K | 531K | 510K | 550K | 334K | 1.24M | 1.35M |
Other Current Assets | 4.82M | 2.52M | 5.49M | 1.96M | 799K | n/a | 1.13M | 541K | 867K | 1.1M | 1.29M | 1.06M | 1.36M | 2.22M | 3.18M | 2.44M | 1.73M | 551K |
Total Current Assets | 68.44M | 49.96M | 41.02M | 29.75M | 25.43M | 24.26M | 26.84M | 27.16M | 26.33M | 19.12M | 20M | 16.42M | 19.78M | 18.75M | 23.6M | 25.86M | 29.07M | 30.27M |
Property-Plant & Equipment | 342K | 180K | 209K | 226K | 255K | 131K | 150K | 147K | 195K | 225K | 260K | 115K | 150K | 193K | 219K | 257K | 299K | 339K |
Goodwill & Intangibles | 32.88M | 33.88M | 34.88M | 5.85M | 6.12M | 6.39M | 4.74M | 4.21M | 4.39M | 4.57M | 4.75M | 4.97M | 3.11M | 4.24M | 3.62M | 463K | 500K | 537K |
Total Long-Term Assets | 33.23M | 34.07M | 35.1M | 6.09M | 6.39M | 6.53M | 4.9M | 4.37M | 4.6M | 4.81M | 5.03M | 5.1M | 3.27M | 4.45M | 3.86M | 743K | 831K | 912K |
Total Assets | 101.68M | 84.03M | 76.12M | 35.84M | 31.82M | 30.79M | 31.74M | 31.53M | 30.93M | 23.93M | 25.03M | 21.52M | 23.05M | 23.2M | 27.46M | 26.61M | 29.91M | 31.19M |
Account Payables | 12.14M | 4.87M | 4.17M | 2.68M | 2.13M | 2.26M | 1.85M | 1.71M | 2.3M | 1.23M | 1.77M | 1.05M | 1.3M | 2.13M | 1.77M | 3.27M | 1.52M | 1.76M |
Deferred Revenue | 330K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -79K | n/a | n/a | n/a | n/a |
Short-Term Debt | 2.79M | n/a | n/a | 4.13M | 4.66M | 5.02M | 5.38M | 1.54M | 1.54M | 1.34M | 1.03M | 708K | 364K | n/a | 1.42M | 1.09M | 749K | 726K |
Other Current Liabilities | 23.3M | n/a | 15.74M | n/a | n/a | -87K | -53K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Liabilities | 38.6M | 25.35M | 19.95M | 19.73M | 18.22M | 15.3M | 16.24M | 10.39M | 9.59M | 7.49M | 6.46M | 4.66M | 3.81M | 3.48M | 4.56M | 5.36M | 3.11M | 3.2M |
Long-Term Debt | 492K | 29.99M | 29.81M | n/a | n/a | n/a | n/a | 4.2M | 4.55M | 5.11M | 5.38M | 5.68M | 5.99M | 6.33M | 5.26M | 5.55M | 6.01M | 6.35M |
Other Long-Term Liabilities | 38.63M | 4.15M | 1.83M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 39.12M | 34.23M | 31.75M | 126K | 145K | n/a | 22K | 4.24M | 4.62M | 5.19M | 5.49M | 5.68M | 5.99M | 6.33M | 5.28M | 5.59M | 6.06M | 6.43M |
Total Liabilities | 77.72M | 59.58M | 51.7M | 19.86M | 18.36M | 15.3M | 16.26M | 14.63M | 14.21M | 12.69M | 11.95M | 10.34M | 9.8M | 9.81M | 9.84M | 10.95M | 9.17M | 9.63M |
Total Debt | 3.26M | 30.08M | 29.92M | 126K | 4.88M | 5.11M | 5.46M | 5.78M | 6.16M | 6.53M | 6.52M | 6.39M | 6.36M | 6.33M | 6.7M | 6.68M | 6.81M | 7.16M |
Common Stock | 27K | 27K | 27K | 26K | 26K | 26K | 26K | 26K | 26K | 26K | 25K | 25K | 25K | 25K | 25K | 25K | 25K | 24K |
Retained Earnings | -112.05M | -109.47M | -107.89M | -107.3M | -107.92M | -104.88M | -104.07M | -101.81M | -101.23M | -105.79M | -103.13M | -104.05M | -101M | -99.44M | -94.11M | -95.15M | -89.06M | -87.04M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.00 | n/a | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | 23.96M | 24.45M | 24.43M | 15.98M | 13.46M | 15.49M | 15.48M | 16.89M | 16.73M | 11.24M | 13.08M | 11.18M | 13.24M | 13.38M | 17.63M | 15.66M | 20.74M | 21.55M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |